Blocking Blog calprotectin elisa camp elisa Elisa hama antibodies hmgb1 elisa iron assay Monoclonal p24 elisa Pcr pge2 elisa rna Serum tbars assay kit upp1 Vector
Diagnostic approaches to respiratory abnormalities in craniofacial syndromes
Craniofacial syndromes are a posh cluster of genetic situations characterised by embryonic perturbations within the developmental trajectory of the higher airway and associated buildings. The presence of diminished airway dimension and maladaptive neuromuscular responses, significantly throughout sleep, results in vital alterations in sleep structure and general detrimental gasoline alternate abnormalities that may be life-threatening.
The widespread want for multi-stage therapeutic interventions for these craniofacial issues requires cautious titration of anatomy and performance, and the latter is presently evaluated by in a single day polysomnography in sleep laboratories. The associated fee, inconvenience, and shortage of pediatric sleep laboratories preclude the frequent evaluations that might optimize the general technique of therapy and corresponding outcomes.
Right here, we critically look at reductionist approaches to polysomnography in youngsters to determine the parallel approximation of such methods to toddler with craniofacial issues. The necessity for potential longitudinal multicenter research with side-by-side comparisons geared toward figuring out an optimum diagnostic and long-term monitoring paradigm for these probably life-threatening situations is emphasised.
A Unifying Strategy for GFR Estimation: Suggestions of the NKF-ASN Job Pressure on Reassessing the Inclusion of Race in Diagnosing Kidney Illness
A Job Pressure from the NKF and ASN developed suggestions for reassessing inclusion of race within the estimation of glomerular filtration price (eGFR) within the U.S. The Job Pressure recommends instant implementation of the CKD-EPI creatinine equation refit with out the race variable in all laboratories as a result of the calculation doesn’t embody race, it included variety in its growth, its potential hostile penalties don’t disproportionately have an effect on anybody group, and it’s instantly obtainable to all laborataries.
A second advice requires nationwide efforts to facilitate elevated, routine, and well timed use of cystatin C, particularly to substantiate eGFR in adults for medical decision-making. A 3rd advice encourages analysis on GFR estimation with new endogenous filtration markers and interventions to get rid of racial and ethnic disparities.
Evaluating errors within the laboratory identification of von Willebrand illness utilizing modern von Willebrand issue assays
von Willebrand illness (VWD) arises from deficiency and/or defects of von Willebrand issue (VWF). Evaluation requires take a look at panels, together with VWF exercise and antigen. Acceptable prognosis together with differential identification of qualitative versus quantitative defects stays problematic however has vital administration implications.
Information utilizing a big set (n=27) of various plasma samples comprising each quantitative VWF deficiency (‘Sort 1 and three’) vs qualitative defects (‘Sort 2’) examined in a cross-laboratory setting have been evaluated to evaluate modern VWF assays for utility to differentially determine pattern sorts. Totally different VWF assays and exercise/antigen ratios confirmed completely different utility in VWD and sort identification.
Identification errors have been linked to assay limitations, together with variability, and laboratory points (e.g., take a look at consequence misinterpretation). Quantitative poor (sort 1) samples have been misinterpreted as qualitative defects (sort 2) on 35/467 events (7.5% error price); 11.4% of those errors have been resulting from laboratories misinterpreting their very own knowledge, which was as a substitute in step with quantitative deficiencies.
Conversely, qualitative defects have been misinterpreted as quantitative deficiencies at a better error price (14.3%), however this was extra typically resulting from laboratories misinterpreting their knowledge (40% of errors). For test-associated errors, VWF:RCo and VWF:GPIbM have been related to the best variability and error price, which was many-fold increased than that utilizing VWF:CB. Chemiluminescence (‘CLIA’) procedures have been related to lowest inter-laboratory variability and errors general.
These findings partially clarify the excessive price of errors related to VWD prognosis. VWF:GPIbM confirmed a surprisingly excessive price of take a look at related errors, while CLIA procedures carried out finest general.
Phthalate Toxicity in Rats and Its Relation to Testicular Dysgenesis Syndrome in People
This work describes the relevance of toxicology research of environmental chemical compounds, with a deal with phthalates, for a speculation that sure human male reproductive issues and ailments have a typical etiology of disturbance of regular growth in utero.
The “Testicular Dysgenesis Syndrome” speculation in people has parallels in male reproductive tract abnormalities and microscopic lesions reported for phthalate toxicity in rats. Moreover, this work describes the histological findings of irregular testicular growth (testicular dysgenesis) in rats as in comparison with these in people, in addition to potential findings in rats at completely different ages, from the embryo to the grownup.
Sodium Ranges Predict Incapacity at Discharge in Guillain-Barré Syndrome: A Retrospective Cohort Research
Guillain-Barré syndrome (GBS) is an inflammatory polyradiculopathy with probably extreme problems. Medical instruments for danger stratification have been developed, however no definitive prognostic biomarker has been reported. Hyponatremia is frequent in GBS sufferers, however the influence of serum sodium ranges on medical outcomes continues to be ill-defined.
On this retrospective cohort examine, we included all grownup sufferers recognized with GBS spectrum issues at our heart from January 2010 to July 2020. Incapacity at discharge was assessed with the GBS Incapacity Rating (GDS), and all medical and laboratory knowledge was retrieved from medical charts.
Thirty (58.8%) of the 51 topics included within the examine have been discharged with extreme residual incapacity (GDS ≥ 3). After accounting for related confounders, the chances of experiencing extreme incapacity decreased by 27% (p = 0.027) for every unitary improve in serum sodium focus. 13 (25.5%) sufferers have been recognized with gentle to average hyponatremia; using intravenous immune globulin (IVIG) independently elevated the chances of growing hyponatremia.
In conclusion, we discovered a big, impartial affiliation between baseline serum sodium ranges and extreme incapacity at discharge in GBS sufferers. In our cohort, hyponatremia was extra continuously noticed after therapy with IVIG, suggesting dilutional pseudohyponatremia as a possible trigger.
Government abstract of the KDIGO 2021 Guideline for the Administration of Glomerular Ailments
The Kidney Illness: Enhancing International Outcomes (KDIGO) Medical Follow Guideline for the Administration of Glomerular Ailments is an replace to the KDIGO 2012 guideline. The purpose is to help clinicians caring for people with glomerulonephritis (GN), each adults and youngsters.
The scope consists of varied glomerular ailments, together with IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, minimal change illness (MCD), focal segmental glomerulosclerosis (FSGS), infection-related GN, antineutrophil cytoplasmic antibody (ANCA) vasculitis, lupus nephritis, and anti-glomerular basement membrane antibody GN.
As well as, this guideline would be the first to deal with the subtype of complement-mediated ailments. Every chapter follows the identical format offering steerage associated to prognosis, prognosis, therapy, and particular conditions.
The aim of the rule is to generate a helpful useful resource for clinicians and sufferers by offering actionable suggestions primarily based on proof syntheses, with helpful infographics incorporating views from specialists within the subject. One other purpose is to suggest analysis suggestions for areas the place there are gaps in data.
EHF (Epidemic Hemorrhagic Fever Virus Antibody IgM) ELISA test |
|||
| 144 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of EHF (Epidemic Hemorrhagic Fever Virus Antibody IgM) |
|||
Human anti-epidemic hemorrhagic fever virus antibody(IgG)ELISA Kit |
|||
| CSB-E09107h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Qualitative indirect ELISA kit for measuring Human anti-epidemic hemorrhagic fever virus antibody (IgG) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human anti-epidemic hemorrhagic fever virus antibody(IgG)ELISA Kit |
|||
| 1-CSB-E09107h | Cusabio |
|
|
|
Description: Qualitative indirect ELISA kit for measuring Human anti-epidemic hemorrhagic fever virus antibody(IgG) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Crimean-Congo Hemorrhagic Fever Virus (CCHF) ELISA Kit |
|||
| abx055690-96tests | Abbexa | 96 tests | EUR 801.6 |
Crimean-Congo hemorrhagic fever virus One-Step PCR kit |
|||
| Oneq-VH060-100R | Bioingentech | 100T | EUR 1932 |
Crimean-Congo hemorrhagic fever virus One-Step PCR kit |
|||
| Oneq-VH060-150R | Bioingentech | 150T | EUR 2646 |
Crimean-Congo hemorrhagic fever virus One-Step PCR kit |
|||
| Oneq-VH060-50R | Bioingentech | 50T | EUR 1410 |
Ebola hemorrhagic fever Virus (Sudan, SEBOV) RT PCR kit |
|||
| RTq-H703-100R | Bioingentech | 100T | EUR 1573.2 |
Ebola hemorrhagic fever Virus (Sudan, SEBOV) RT PCR kit |
|||
| RTq-H703-150R | Bioingentech | 150T | EUR 2144.4 |
Ebola hemorrhagic fever Virus (Sudan, SEBOV) RT PCR kit |
|||
| RTq-H703-50R | Bioingentech | 50T | EUR 1155.6 |
Human anti-epidemic hemorrhagic fever virus(EHF) antibody(IgM) ELISA Kit |
|||
| CSB-E09553h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Qualitative indirect ELISA kit for measuring Human anti-epidemic hemorrhagic fever virus (EHF) antibody (IgM) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human anti-epidemic hemorrhagic fever virus(EHF) antibody(IgM) ELISA Kit |
|||
| 1-CSB-E09553h | Cusabio |
|
|
|
Description: Qualitative indirect ELISA kit for measuring Human anti-epidemic hemorrhagic fever virus(EHF) antibody(IgM) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
ELISA kit for Human Anti-epidemic hemorrhagic fever virus antibody (IgG) |
|||
| KTE62463-48T | Abbkine | 48T | EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Anti-epidemic hemorrhagic fever virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Anti-epidemic hemorrhagic fever virus antibody (IgG) |
|||
| KTE62463-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Human Anti-epidemic hemorrhagic fever virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Anti-epidemic hemorrhagic fever virus antibody (IgG) |
|||
| KTE62463-96T | Abbkine | 96T | EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Human Anti-epidemic hemorrhagic fever virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Ebola hemorrhagic fever Virus (Sudan, SEBOV) One-Step PCR kit |
|||
| Oneq-H703-100R | Bioingentech | 100T | EUR 1932 |
Ebola hemorrhagic fever Virus (Sudan, SEBOV) One-Step PCR kit |
|||
| Oneq-H703-150R | Bioingentech | 150T | EUR 2646 |
Ebola hemorrhagic fever Virus (Sudan, SEBOV) One-Step PCR kit |
|||
| Oneq-H703-50R | Bioingentech | 50T | EUR 1410 |
Human anti-epidemic hemorrhagic fever virus IgG antibody,EHF IgG elisa Kit |
|||
| CN-04996H1 | ChemNorm | 96T | EUR 579.6 |
Human anti-epidemic hemorrhagic fever virus IgG antibody,EHF IgG elisa Kit |
|||
| CN-04996H2 | ChemNorm | 48T | EUR 399.6 |
ELISA kit for Human anti-epidemic hemorrhagic fever virus (EHF) antibody (IgM) |
|||
| EK0147 | SAB | 96 tests | EUR 934.8 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-epidemic hemorrhagic fever virus (EHF) antibody (IgM) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Human anti-epidemic hemorrhagic fever virus IgM antibody,EHF IgM ELISA Kit |
|||
| 201-12-1576 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human anti-epidemic hemorrhagic fever virus IgG antibody,EHF IgG ELISA Kit |
|||
| 201-12-1585 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human anti-epidemic hemorrhagic fever virus IgM antibody(EHF IgM)ELISA Kit |
|||
| GA-E1592HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human anti-epidemic hemorrhagic fever virus IgM antibody(EHF IgM)ELISA Kit |
|||
| GA-E1592HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human anti-epidemic hemorrhagic fever virus IgG antibody(EHF IgG)ELISA Kit |
|||
| GA-E1601HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human anti-epidemic hemorrhagic fever virus IgG antibody(EHF IgG)ELISA Kit |
|||
| GA-E1601HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human anti-epidemic hemorrhagic fever virus IgM antibody(EHF IgM)ELISA Kit |
|||
| QY-E02589 | Qayee Biotechnology | 96T | EUR 433.2 |
Human anti-epidemic hemorrhagic fever virus IgG antibody(EHF IgG)ELISA Kit |
|||
| QY-E02590 | Qayee Biotechnology | 96T | EUR 433.2 |
Canine anti-epidemic hemorrhagic fever virus IgG antibody,EHF IgG ELISA KIT |
|||
| QY-E70152 | Qayee Biotechnology | 96T | EUR 511.2 |
Human Crimean-Congo Hemorrhagic Fever Virus IgG (CCHF-IgG) ELISA Kit |
|||
| abx157316-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Crimean-Congo Hemorrhagic Fever Virus IgM (CCHF-IgM) ELISA Kit |
|||
| abx055433-96tests | Abbexa | 96 tests | EUR 801.6 |
ELISA kit for Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit |
|||
| KTE62936-48T | Abbkine | 48T | EUR 424.8 |
|
Description: Quantitative sandwich ELISA for measuring Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit |
|||
| KTE62936-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2702.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit |
|||
| KTE62936-96T | Abbkine | 96T | EUR 686.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Crimean?Congo hemorrhagic fever Virus (CCHFV) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Human Crimean Congo Hemorrhagic Fever Virus IgG, CCHF-IgG ELISA kit |
|||
| YLA4179HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human Crimean Congo Hemorrhagic Fever Virus IgG, CCHF-IgG ELISA kit |
|||
| YLA4179HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
ELISA kit for Human anti-epidemic hemorrhagic fever virus antibody (IgG)ELISA Kit |
|||
| EK0146 | SAB | 96 tests | EUR 934.8 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-epidemic hemorrhagic fever virus antibody (IgG)ELISA Kit in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat epidemic hemorrhagic fever antibody(IgG) ELISA kit |
|||
| CSB-E12810r-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Qualitative indirect ELISA kit for measuring Rat epidemic hemorrhagic fever antibody (IgG) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Rat epidemic hemorrhagic fever antibody(IgG) ELISA kit |
|||
| 1-CSB-E12810r | Cusabio |
|
|
|
Description: Qualitative indirect ELISA kit for measuring Rat epidemic hemorrhagic fever antibody(IgG) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Epidemic Hemorrhagic Fever Antibody (EHFAb) ELISA Kit |
|||
| abx054813-96tests | Abbexa | 96 tests | EUR 801.6 |
Rift Valley Fever Virus Antibody |
|||
| 4519-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: Rift Valley Fever Virus Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes. During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity. The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins. This RVF virus antibody was derived from a peptide sequence near the center of the polyprotein precursor translated from the M segment. It will therefore detect both the precursor and the Glycoprotein G1. |
|||
Rift Valley Fever Virus Antibody |
|||
| 4519-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: Rift Valley Fever Virus Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes. During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity. The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins. This RVF virus antibody was derived from a peptide sequence near the center of the polyprotein precursor translated from the M segment. It will therefore detect both the precursor and the Glycoprotein G1. |
|||
Rift Valley Fever Virus Antibody |
|||
| 4521-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: Rift Valley Fever Virus Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes. During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity. The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins. |
|||
Rift Valley Fever Virus Antibody |
|||
| 4521-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: Rift Valley Fever Virus Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes. During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity. The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins. |
|||
Rift Valley Fever Virus Antibody |
|||
| 24652-100ul | SAB | 100ul | EUR 468 |
Rift Valley Fever Virus Antibody |
|||
| 24653-100ul | SAB | 100ul | EUR 468 |
Yellow Fever Virus (YFV) Antibody |
|||
| abx415761-01mg | Abbexa | 0.1 mg | EUR 710.4 |
Yellow Fever Virus (YFV) Antibody |
|||
| abx411683-01ml | Abbexa | 0.1 ml | EUR 610.8 |
Mouse Crimean-Congo hemorrhagic fever virus (CCHFV) IgG ELISA Kit, 96 tests, Quantitative |
|||
| AE-320400-1 | Alpha Diagnostics | 1 kit | EUR 927.6 |
Mouse Crimean-Congo hemorrhagic fever virus (CCHFV) IgM ELISA Kit, 96 tests, Quantitative |
|||
| AE-320410-1 | Alpha Diagnostics | 1 kit | EUR 927.6 |
Human Crimean-Congo hemorrhagic fever virus (CCHFV) IgG ELISA Kit, 96 tests, Quantitative |
|||
| AE-320420-1 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Human Crimean-Congo hemorrhagic fever virus (CCHFV) IgM ELISA Kit, 96 tests, Quantitative |
|||
| AE-320430-1 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Rabbit Crimean-Congo hemorrhagic fever virus (CCHFV) IgG ELISA Kit, 96 tests, Quantitative |
|||
| AE-320440-1 | Alpha Diagnostics | 1 kit | EUR 927.6 |
ELISA kit for Rat Epidemic hemorrhagic fever (IgG) antibody |
|||
| KTE100946-48T | Abbkine | 48T | EUR 424.8 |
|
Description: Quantitative sandwich ELISA for measuring Rat Epidemic hemorrhagic fever (IgG) antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Rat Epidemic hemorrhagic fever (IgG) antibody |
|||
| KTE100946-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2702.4 |
|
Description: Quantitative sandwich ELISA for measuring Rat Epidemic hemorrhagic fever (IgG) antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Rat Epidemic hemorrhagic fever (IgG) antibody |
|||
| KTE100946-96T | Abbkine | 96T | EUR 686.4 |
|
Description: Quantitative sandwich ELISA for measuring Rat Epidemic hemorrhagic fever (IgG) antibody in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Virus Yellow Fever Virus (YFV) Protein |
|||
| abx670277-100ug | Abbexa | 100 ug | EUR 644.4 |
Rabbit Anti-Crimean-Congo hemorrhagic fever virus nucleoprotein protein (CCHFV-NP, full length) antiserum |
|||
| CCHFV11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Human Epidemic Hemorrhagic Fever Antibody IgG (EHF-IgG) ELISA Kit |
|||
| abx054767-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Epidemic Hemorrhagic Fever Antibody IgM (EHF-IgM) ELISA Kit |
|||
| abx054768-96tests | Abbexa | 96 tests | EUR 801.6 |
Rift Valley Fever Virus Nucleocapsid Antibody |
|||
| 7413-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: Rift Valley Fever Virus Nucleocapsid Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes (1). During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity (2). The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins (3). |
|||
Rift Valley Fever Virus Nucleocapsid Antibody |
|||
| 7413-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: Rift Valley Fever Virus Nucleocapsid Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes (1). During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity (2). The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins (3). |
|||
Rift Valley Fever Virus Polymerase Antibody |
|||
| 7415-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: Rift Valley Fever Virus Polymerase Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes (1). During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity (2). The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins (3). |
|||
Rift Valley Fever Virus Polymerase Antibody |
|||
| 7415-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: Rift Valley Fever Virus Polymerase Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes (1). During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity (2). The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins (3). |
|||
Mouse antibody for Yellow Fever virus |
|||
| 3576 | Virostat | 100 ug | EUR 425.4 |
|
Description: This is purified Mouse monoclonal antibody against Yellow Fever virus for WB, ELISA. |
|||
Rabbit Hemorrhagic disease virus ELISA Kit |
|||
| abx157237-96tests | Abbexa | 96 tests | EUR 801.6 |
Epizootic hemorrhagic diesase virus PCR kit |
|||
| PCR-V229-48R | Bioingentech | 50T | EUR 987.6 |
Epizootic hemorrhagic diesase virus PCR kit |
|||
| PCR-V229-96R | Bioingentech | 100T | EUR 1335.6 |
Viral hemorrhagic septicemia virus PCR kit |
|||
| PCR-V264-48R | Bioingentech | 50T | EUR 987.6 |
Viral hemorrhagic septicemia virus PCR kit |
|||
| PCR-V264-96R | Bioingentech | 100T | EUR 1335.6 |
Human anti-epidemic hemorrhagic fever ,EHF Ab ELISA Kit |
|||
| 201-12-2049 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human epidemic hemorrhagic fever IgG,EHF IgG ELISA Kit |
|||
| 201-12-2055 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human epidemic hemorrhagic fever IgM,EHF IgM ELISA Kit |
|||
| 201-12-2056 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human epidemic hemorrhagic fever IgM(EHF IgM)ELISA Kit |
|||
| QY-E02253 | Qayee Biotechnology | 96T | EUR 433.2 |
Human epidemic hemorrhagic fever IgG(EHF IgG)ELISA Kit |
|||
| QY-E02254 | Qayee Biotechnology | 96T | EUR 433.2 |
Human anti-epidemic hemorrhagic fever(EHF Ab)ELISA Kit |
|||
| QY-E02591 | Qayee Biotechnology | 96T | EUR 433.2 |
Yellow fever virus Genome polyprotein |
|||
| 1-CSB-EP365905YAC1 | Cusabio |
|
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
|||
Rift Valley Fever Virus Peptide |
|||
| 4519P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) Rift Valley Fever Virus peptide |
|||
Rift Valley Fever Virus Peptide |
|||
| 4521P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (CT) Rift Valley Fever Virus peptide |
|||
Yellow Fever Virus NS1 protein |
|||
| 80-1547 | Fitzgerald | 500 ug | EUR 2108.4 |
|
Description: Purified Recombinant Yellow Fever Virus NS1 protein (His tag) |
|||
Yellow fever virus PCR kit |
|||
| PCR-H627-48D | Bioingentech | 50T | EUR 543.6 |
Yellow fever virus PCR kit |
|||
| PCR-H627-96D | Bioingentech | 100T | EUR 686.4 |
Recombinant (E.coli) Crimean-Congo hemorrhagic fever virus nucleoprotein protein (full length, his-tag, 55 kda), purified |
|||
| CCHFV15-R-10 | Alpha Diagnostics | 10 ug | EUR 416.4 |
Epizootic hemorrhagic diesase virus RT PCR kit |
|||
| RTq-V229-100R | Bioingentech | 100T | EUR 1573.2 |
Epizootic hemorrhagic diesase virus RT PCR kit |
|||
| RTq-V229-150R | Bioingentech | 150T | EUR 2144.4 |
Epizootic hemorrhagic diesase virus RT PCR kit |
|||
| RTq-V229-50R | Bioingentech | 50T | EUR 1155.6 |
Viral hemorrhagic septicemia virus RT PCR kit |
|||
| RTq-V264-100R | Bioingentech | 100T | EUR 1573.2 |
Viral hemorrhagic septicemia virus RT PCR kit |
|||
| RTq-V264-150R | Bioingentech | 150T | EUR 2144.4 |
Viral hemorrhagic septicemia virus RT PCR kit |
|||
| RTq-V264-50R | Bioingentech | 50T | EUR 1155.6 |
Recombinant yellow fever virus Env protein |
|||
| DAG832 | Creative Diagnostics | 1 mg | EUR 858 |
Classical Swine Fever Virus E2 Protein |
|||
| AG05-0313-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 333.6 |
Rift valley fever virus Nucleoprotein (N) |
|||
| 1-CSB-EP322011REV | Cusabio |
|
|
|
Description: Recombinant Rift valley fever virus Nucleoprotein(N) expressed in E.coli |
|||
Rift Valley Fever Virus Nucleocapsid Peptide |
|||
| 7413P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) Rift Valley Fever Virus Nucleocapsid Peptide |
|||
Rift Valley Fever Virus Polymerase Peptide |
|||
| 7415P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) Rift Valley Fever Virus Polmerase Peptide |
|||
African swine fever virus PCR kit |
|||
| PCR-V121-48D | Bioingentech | 50T | EUR 543.6 |
African swine fever virus PCR kit |
|||
| PCR-V121-96D | Bioingentech | 100T | EUR 686.4 |
Classical swine fever virus PCR kit |
|||
| PCR-V130-48R | Bioingentech | 50T | EUR 987.6 |
Classical swine fever virus PCR kit |
|||
| PCR-V130-96R | Bioingentech | 100T | EUR 1335.6 |
Yellow fever virus RT PCR kit |
|||
| RTq-H627-100D | Bioingentech | 100T | EUR 860.4 |
Yellow fever virus RT PCR kit |
|||
| RTq-H627-150D | Bioingentech | 150T | EUR 969.6 |
Yellow fever virus RT PCR kit |
|||
| RTq-H627-50D | Bioingentech | 50T | EUR 717.6 |
QPCR Kit RNA Yellow Fever virus |
|||
| MOL8392 | Scientific Laboratory Supplies | EACH | EUR 839.04 |
QPCR Kit RNA Yellow Fever virus |
|||
| MOL8394 | Scientific Laboratory Supplies | EACH | EUR 1097.82 |
Taura syndrome virus PCR kit |
|||
| PCR-V293-48R | Bioingentech | 50T | EUR 987.6 |
Taura syndrome virus PCR kit |
|||
| PCR-V293-96R | Bioingentech | 100T | EUR 1335.6 |
Classical Swine Fever Virus Antibody(IgG) ELISA Kit |
|||
| CSB-E12765p-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Qualitativeindirect ELISA kit for measuring Classical Swine Fever Virus Antibody (IgG) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Classical Swine Fever Virus Antibody(IgG) ELISA Kit |
|||
| 1-CSB-E12765p | Cusabio |
|
|
|
Description: Qualitativeindirect ELISA kit for measuring Classical Swine Fever Virus Antibody(IgG) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Classical Porcine Fever Virus Total Antibody ELISA Kit |
|||
| RK04110 | Abclonal | 96T | EUR 625.2 |
Classical Porcine Fever Virus Neutralizing Antibody ELISA Kit |
|||
| RK04111 | Abclonal | 96T | EUR 625.2 |
Epizootic hemorrhagic diesase virus One-Step PCR kit |
|||
| Oneq-V229-100R | Bioingentech | 100T | EUR 1932 |
Epizootic hemorrhagic diesase virus One-Step PCR kit |
|||
| Oneq-V229-150R | Bioingentech | 150T | EUR 2646 |
Epizootic hemorrhagic diesase virus One-Step PCR kit |
|||
| Oneq-V229-50R | Bioingentech | 50T | EUR 1410 |
Viral hemorrhagic septicemia virus One-Step PCR kit |
|||
| Oneq-V264-100R | Bioingentech | 100T | EUR 1932 |
Viral hemorrhagic septicemia virus One-Step PCR kit |
|||
| Oneq-V264-150R | Bioingentech | 150T | EUR 2646 |
Viral hemorrhagic septicemia virus One-Step PCR kit |
|||
| Oneq-V264-50R | Bioingentech | 50T | EUR 1410 |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Crimean-Congo hemorrhagic fever virus (CCHFV) by ELISA |
|||
| AE-320430-CUX | Alpha Diagnostics | Custom | Ask for price |
Yellow fever virus infectious culture fluid(17D) |
|||
| DAGF-040 | Creative Diagnostics | 1ml | EUR 774 |
Bovine Ephemeral Fever Virus (BEFV) ELISA Kit |
|||
| abx055786-96tests | Abbexa | 96 tests | EUR 886.8 |
Yellow fever virus One-Step PCR kit |
|||
| Oneq-H627-100D | Bioingentech | 100T | EUR 1039.2 |
Yellow fever virus One-Step PCR kit |
|||
| Oneq-H627-150D | Bioingentech | 150T | EUR 1177.2 |
Yellow fever virus One-Step PCR kit |
|||
| Oneq-H627-50D | Bioingentech | 50T | EUR 861.6 |
The rule of thumb targets a broad world viewers of clinicians treating GN whereas being conscious of implications for coverage and price. Growth of this guideline replace adopted an specific course of whereby therapy approaches and guideline suggestions are primarily based on systematic opinions of related research, and appraisal of the standard of the proof and the power of suggestions adopted the “Grading of Suggestions Evaluation, Growth and Analysis” (GRADE) strategy. Limitations of the proof are mentioned, with areas of future analysis additionally offered.
![Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson's Disease](https://www.holliseden.com/rg/uploads/2021/09/5.jpg)